RASFF Notifications: Food Supplements and Fraud
Analysis shows: Food supplements frequently involved in RASFF fraud notifications - pharmaceuticals and composition in focus.
# RASFF Notifications: Food Supplements and Fraud
Analysis shows: Food supplements frequently involved in RASFF fraud notifications - pharmaceuticals and composition in focus.
Background
Analysis of RASFF data shows food supplements are frequently involved in fraud notifications, with common issues including compositional problems, novel foods, and unauthorized pharmaceuticals.
Key Statements
- Important regulatory developments in the field of food supplements
- Impacts on manufacturers and consumers
- Compliance requirements must be observed
Impact for Manufacturers
Manufacturers must carefully review the new requirements and adjust their products accordingly.
Recommendations
- Continuously monitor regulatory developments
- Adapt your compliance processes
- Consult legal experts if necessary
- Document all changes carefully
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific legal questions, please consult a lawyer specialized in food law.
Source: [MDPI Sustainability](https://www.mdpi.com/2071-1050/16/15/6545)
*Hinweis: Diese Zusammenfassung dient Informationszwecken. Die dargestellten Studienergebnisse sind keine zugelassenen Health Claims. Für detaillierte Informationen konsultieren Sie bitte die Originalquelle.
Related Posts
More articles from this category
ANSES Warns About Food Supplement Risks and Misconceptions
ANSES and ANSM emphasize that despite being widely consumed, food supplements are not innocuous and can pose health risks, particularly when consumed without professional advice.
France Bans Garcinia Cambogia Supplements Due to Severe Health Risks
In April 2025, France implemented a ban on food supplements containing Garcinia cambogia following ANSES opinion identifying severe adverse effects including hepatic damage, with one death reported.
EFSA Novel Food Approval: Industry Criticizes Process
Doubled costs and seven months processing time: Industry criticizes EFSA approval procedure.